BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/28/2020 1:45:47 AM | Browse: 649 | Download: 1413
 |
Received |
|
2020-03-03 02:23 |
|
Peer-Review Started |
|
2020-03-03 02:33 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-25 18:26 |
|
Revised |
|
2020-08-09 01:20 |
|
Second Decision |
|
2020-09-01 11:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-01 19:34 |
|
Articles in Press |
|
2020-09-01 19:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-22 09:34 |
|
Publish the Manuscript Online |
|
2020-09-28 01:45 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong Beum Kim, Hee Jeong Lee, Ran Hong and Sang-Gon Park |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning |
NRF-2017R1C1B5076793 |
| grants from the Chosun University Hospital |
2019 |
| National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning |
NRF-2017R1D1A1B04031741 |
|
| Corresponding Author |
Hee Jeong Lee, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, 365 Pilmun-daero, Dong-gu, Gwangju 505717, South Korea. hjangel21c@hanmail.net |
| Key Words |
Ovarian undifferentiated carcinoma; Sarcomatoid change; Chemotherapy; Etoposide, ifosfamide, cisplatin; Case report; |
| Core Tip |
Palliative chemotherapy is the only available treatment for metastatic ovarian undifferentiated carcinoma. However, we used a high-dose combination chemotherapy of etoposide, ifosfamide, and cisplatin instead of the widely used paclitaxel and platinum and successfully treated an extremely rare case of inoperable metastatic ovarian undifferentiated carcinoma. |
| Publish Date |
2020-09-28 01:45 |
| Citation |
Kim HB, Lee HJ, Hong R, Park SG. Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report. World J Clin Cases 2020; 8(19): 4488-4493 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i19/4488.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i19.4488 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
